![]()
![]()
![]()
Prescriber's
Guidelines -
(con't)
These guidelines were developed for the use by Stony Brook University
Hospital’s Acute Pain Service.
|
Opioid Analgesics Starting Oral - Dose Commonly Used for Severe Pain. |
||||
|
|
Starting Oral Dose |
|||
|
Name |
Equianalgesic Dose (mg) |
Adults |
Children |
|
|
Morphine-like agonists |
Oral |
Parenteral* |
(mg) |
(mg/kg) |
|
Morphine |
30 |
10 |
15-30 |
0.30 |
|
Hydromorphone (Dilaudid) |
7.5 |
1.5 |
4-8 |
0.06 |
|
Oxycodone |
20 |
----- |
15-30 |
0.20 |
|
Methadone (Dolopine) |
20 acute |
10 acute 2-4 chronic |
5-10 |
0.20 |
| Fentanyl | ----- | 0.1 | ----- | ----- |
|
Comments:
Standard of comparison for opioid analgesics. Sustained-release preparations
(MS Contin, OramorphSR) release drug over 8-12 hours. Recent addition of
once-a-day sustained release formulation (Kadian). Slightly shorter duration
than morphine. Good oral potency, long plasma half-life (24-36 hours).
Transdermal fentanyl (Duragesic) 25
mcg/hour, roughly equivalent to sustained-release morphine, 45mg/day. Oral
transmucosal fentanyl citrate now available for treatment of breakthrough
pain in chronic cancer pain patients already taking around-the-clock
opioids. |
||||
